Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Chemical Allergen [EPC]
Povidone (polyvinylpyrrolidone) is a versatile synthetic polymer used as a plasma volume expander, an ophthalmic lubricant, and a pharmaceutical excipient. It is also classified as a non-standardized chemical allergen.
Name
Povidone
Raw Name
POVIDONE
Category
Non-Standardized Chemical Allergen [EPC]
Drug Count
47
Variant Count
53
Last Verified
February 17, 2026
RxCUI
2625120, 996202, 598050, 2727395, 1235569, 630977, 2570860, 2586186, 2586181, 359969, 2604775
UNII
PDC6A3C0OX, FZ989GH94E, 7SA290YK68, B697894SGQ, 0YZT43HS7D, 532B59J990, 3NXW29V3WO
About Povidone
Povidone (polyvinylpyrrolidone) is a versatile synthetic polymer used as a plasma volume expander, an ophthalmic lubricant, and a pharmaceutical excipient. It is also classified as a non-standardized chemical allergen.
Detailed information about Povidone
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Povidone.
In contemporary clinical practice, povidone serves multiple roles. It is most commonly encountered as a pharmaceutical excipient (an inactive ingredient), where it acts as a binder in tablet formulations to ensure structural integrity and controlled drug release. It is also a primary component in ophthalmic 'artificial tear' solutions used to treat dry eye syndrome (keratoconjunctivitis sicca). Furthermore, povidone is the essential carrier molecule in povidone-iodine (Betadine), where it complexes with elemental iodine to provide a slow-release antiseptic effect. According to the FDA’s inactive ingredient database (2024), povidone is present in thousands of approved drug products ranging from oral solids to topical gels.
The mechanism of action for povidone depends entirely on its route of administration and its specific molecular weight (often denoted by its 'K-value').
When used as a plasma volume expander, povidone exerts Osmotic Activity [MoA]. Because it is a large polymer that does not easily cross the capillary membrane, it increases the oncotic pressure (colvloid osmotic pressure) of the blood. This draws water from the interstitial space (the area between cells) into the intravascular compartment (the blood vessels), thereby increasing total blood volume. This is critical in treating hypovolemic shock resulting from hemorrhage or severe dehydration.
In ophthalmic applications, povidone acts as a demulcent. It forms a protective, hydrophilic (water-loving) film over the corneal surface. This film mimics the action of natural mucins in the tear film, reducing friction during blinking and preventing the evaporation of moisture from the eye surface. Its viscosity-enhancing properties ensure that the lubricant stays on the eye longer than simple saline solutions.
At the molecular level in oral medications, povidone acts as a 'disintegrant' or 'binder.' It has a high affinity for both hydrophilic and hydrophobic molecules, allowing it to stabilize drug formulations. When a tablet containing povidone reaches the stomach, the povidone absorbs water, swells, and facilitates the rapid breakup of the tablet, ensuring the active drug is available for absorption.
The pharmacokinetics of povidone are unique because the human body lacks the enzymes necessary to metabolize the polyvinyl backbone. Its movement through the body is determined almost exclusively by its molecular weight.
> Important: Only your healthcare provider can determine if Povidone is right for your specific condition. While it is often an 'inactive' ingredient, its presence can be clinically significant for patients with specific sensitivities.
For the relief of dry eye symptoms, the standard dosage is 1 to 2 drops in the affected eye(s) as needed. Many clinicians recommend a frequency of 3 to 4 times daily, though it can be used more frequently if the formulation is preservative-free.
For skin disinfection, apply a sufficient amount of povidone-iodine (10%) to the targeted area. Allow it to dry completely to ensure the release of free iodine. The treated area may be bandaged if necessary.
In emergency settings, the dosage of intravenous povidone is highly individualized based on the patient's hemodynamic status, blood loss, and heart rate. Historically, infusions of 500 mL to 1,500 mL of a 3.5% to 4% solution were utilized.
Povidone eye drops are generally considered safe for children when used under adult supervision. The dosage is typically the same as the adult dose (1-2 drops), but parents should consult a pediatrician before beginning treatment for chronic dry eye in children.
Povidone-iodine should be used with caution in newborns and infants. According to a 2023 clinical review, excessive use on the skin of neonates can lead to systemic iodine absorption and transient hypothyroidism.
For patients with severe renal impairment (Stage 4 or 5 Chronic Kidney Disease), systemic (IV) povidone is generally avoided. Because the kidneys are the sole route of elimination for the polymer, there is a high risk of povidone accumulation in tissues.
No specific dosage adjustments are required for topical or ophthalmic povidone in patients with liver disease, as systemic absorption is minimal.
Elderly patients often experience decreased tear production and may require more frequent application of povidone eye drops. However, clinicians should monitor for increased sensitivity to preservatives (like benzalkonium chloride) often found in povidone multi-dose bottles.
Store povidone products at room temperature, typically between 15°C and 30°C (59°F to 86°F). Protect from excessive heat and freezing. Ensure the cap is tightly closed when not in use.
If you are using povidone eye drops on a schedule and miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not 'double up' the drops to make up for a missed application.
An overdose of povidone eye drops is unlikely to cause systemic toxicity. If too many drops are applied, flush the eye with lukewarm water or saline.
If povidone (especially in the form of povidone-iodine) is accidentally swallowed, contact a Poison Control Center immediately. Symptoms of iodine poisoning include a metallic taste, increased salivation, burning in the mouth, and abdominal pain.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. If symptoms persist for more than 72 hours, discontinue use and seek medical attention.
When used as an ophthalmic lubricant, povidone is generally well-tolerated. However, some users may experience:
> Warning: Stop taking Povidone and call your doctor immediately if you experience any of these.
This is a rare but serious condition associated with the long-term systemic (intravenous) administration of high-molecular-weight povidone. Because the body cannot break down the polymer, it accumulates in the macrophages of the liver, spleen, lungs, and lymph nodes. Over years, this can lead to:
If using multi-dose povidone eye drops frequently (more than 4-6 times daily), the preservative benzalkonium chloride can accumulate, leading to 'medicamentosa' or chemically induced conjunctivitis. Switching to preservative-free single-use vials is recommended for chronic users.
There are currently no FDA black box warnings for povidone when used as an ophthalmic lubricant or pharmaceutical excipient. However, clinicians must remain vigilant regarding its classification as a Non-Standardized Chemical Allergen, as it is often an 'invisible' ingredient in many medications.
Report any unusual symptoms to your healthcare provider. If you suspect an allergic reaction, provide the labels of all your current medications to an allergist, as povidone may be listed only as an inactive ingredient.
Povidone is generally recognized as safe (GRAS) by the FDA for use in food and drug products. However, its role as a potential allergen is often overlooked. Patients with a history of 'multiple drug allergies' should be screened for povidone sensitivity, as the polymer is a common binder in many different classes of medications.
No FDA black box warnings for Povidone. It is considered a low-risk substance for the vast majority of the population.
According to a 2022 study in the Journal of Allergy and Clinical Immunology, povidone allergy is an under-recognized cause of perioperative anaphylaxis. Because povidone is used in surgical scrubs (povidone-iodine) and as a lubricant in catheters, sensitized patients may react during medical procedures. If you have ever had an unexplained reaction during surgery or after taking a tablet, povidone may be the culprit.
Most povidone-based eye drops contain preservatives that can be absorbed by soft contact lenses. This can lead to lens discoloration and prolonged contact of the preservative with the cornea, increasing the risk of irritation. Lenses should be removed before applying the drops and left out for at least 15 minutes.
If the tip of a povidone eye drop bottle becomes contaminated, it can lead to serious eye infections. Never touch the dropper tip to any surface. If the solution changes color or becomes cloudy, discard it immediately.
For standard ophthalmic or oral use, no specific laboratory monitoring (like blood counts or liver tests) is required. However, for patients receiving povidone-iodine over large areas of broken skin or burns, the following may be monitored:
Povidone eye drops may cause temporary blurring of vision. Do not drive, operate heavy machinery, or engage in activities requiring clear vision until your sight has fully cleared (usually within a minute of application).
There are no known direct interactions between alcohol and povidone. However, alcohol consumption can exacerbate systemic dehydration, which may worsen the symptoms of dry eye that povidone is intended to treat.
There is no withdrawal syndrome associated with stopping povidone. However, if you are using it for a chronic condition like keratoconjunctivitis sicca, your symptoms (dryness, grittiness, redness) will likely return shortly after you stop using the medication.
> Important: Discuss all your medical conditions with your healthcare provider before starting Povidone, especially if you have a history of severe allergies or thyroid disorders.
There are no absolute drug-drug contraindications for povidone when used as an inactive excipient or an ophthalmic lubricant. However, when povidone is part of the Povidone-Iodine complex, it should not be used simultaneously with:
For patients using povidone-iodine topically over large areas, the absorption of iodine can have an additive effect with lithium on the thyroid gland. Both substances inhibit the release of thyroid hormones, potentially leading to symptomatic hypothyroidism. Patients on lithium therapy should use povidone-iodine sparingly.
If you are using other eye drops (such as glaucoma medications or steroid drops), povidone can act as a barrier or a carrier that alters their absorption.
There are no known food interactions with povidone. It is not absorbed from the gut, so it does not interfere with the metabolism of nutrients. If using povidone-iodine, a high-iodine diet (seaweed, iodized salt) may theoretically increase the risk of thyroid dysfunction if systemic absorption occurs through broken skin.
No significant interactions have been documented with common herbal supplements like St. John's Wort or Ginkgo Biloba. However, supplements containing high levels of iodine (such as Kelp or Bladderwrack) should be used cautiously if you are also using povidone-iodine products.
Povidone-iodine can interfere with several diagnostic tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including 'inactive' ingredients if you have a history of sensitivities.
Patients with a documented allergy to polyvinylpyrrolidone (PVP) must never use products containing povidone. While povidone-iodine allergy is often blamed on the iodine, clinical studies have shown that the povidone polymer itself is frequently the true allergen. Anaphylaxis has been reported in patients sensitized to povidone through previous exposure in hairsprays, cosmetics, or tablet binders.
In the case of povidone-iodine, patients with this rare autoimmune blistering skin condition (associated with celiac disease) should avoid the product, as iodine can trigger a severe flare-up of the rash.
Patients with Graves' disease, nodular goiter, or a history of Hashimoto's thyroiditis should use povidone-iodine with extreme caution. The 'Wolff-Chaikoff effect' describes how a large load of iodine can shut down thyroid hormone production in susceptible individuals.
As noted in the pharmacokinetic section, povidone is cleared by the kidneys. In patients with anuria or end-stage renal disease, the risk of tissue accumulation (thesaurosis) is significantly higher if povidone is administered systemically.
There is no known cross-sensitivity between povidone and other common polymers like polyethylene glycol (PEG) or polysorbate. However, patients who react to one synthetic polymer may be more likely to develop sensitivities to others due to a hyper-reactive immune system. It is important to distinguish between an allergy to 'seafood/shellfish' and an allergy to povidone-iodine; these are not related, as seafood allergies are typically reactions to proteins (tropomyosins), not iodine or povidone.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Povidone or using it in a clinical setting.
Povidone is generally considered safe for use during pregnancy when applied to the eyes or consumed as a tablet binder. It is not systemically absorbed in significant quantities and is unlikely to reach the developing fetus.
Caution is advised for topical povidone-iodine during the second and third trimesters. Iodine readily crosses the placenta. According to the American Thyroid Association (2024), prolonged use on the mother's skin can lead to fetal goiter or congenital hypothyroidism. Short-term use for a single surgical procedure is generally considered acceptable.
Povidone used in eye drops is compatible with breastfeeding. However, povidone-iodine used on the skin (especially the breast area) can result in high iodine concentrations in breast milk. This may lead to transient hypothyroidism in the nursing infant. If povidone-iodine must be used, the infant's thyroid function should be monitored by a pediatrician.
Povidone is widely used in pediatric medicine as a binder in chewable tablets and liquid suspensions. It is generally safe. For dry eye, povidone drops are effective, but clinicians should ensure the child does not have an underlying condition like juvenile rheumatoid arthritis causing the dryness. Povidone-iodine should be avoided in very low birth weight neonates due to their permeable skin and immature thyroid regulation.
Older adults are the primary users of povidone eye drops due to age-related atrophy of the lacrimal glands. While safe, elderly patients are more prone to 'dry eye' being a symptom of other systemic diseases (like Sjögren's syndrome). Clinicians should also consider the manual dexterity of the patient; if they cannot squeeze the bottle correctly, they may not receive the proper dose.
No dosage adjustment is needed for topical or ophthalmic povidone. For historical IV use, povidone is contraindicated in severe renal impairment. In patients with moderate impairment, the half-life of the polymer is significantly extended from several hours to several days.
Since povidone is not metabolized by the liver, no dosage adjustments are required for patients with cirrhosis or hepatitis. Hepatic function does not affect the clearance of povidone from the bloodstream.
> Important: Special populations require individualized medical assessment to weigh the benefits of povidone use against potential systemic risks.
Povidone (Polyvinylpyrrolidone) is a non-ionic, synthetic polymer. Its clinical utility stems from its Osmotic Activity [MoA] and its ability to form complexes. In the blood, it acts as a colloid, exerting oncotic pressure that keeps fluid within the vascular space. On the eye, its 'mucomimetic' properties allow it to bind to the corneal epithelium, providing a long-lasting lubricating film. As an excipient, it acts as a 'polymeric bridge' during the wet granulation process of tablet manufacturing, ensuring that the active pharmaceutical ingredient (API) is evenly distributed and structurally sound.
Povidone is pharmacologically inert, meaning it does not bind to specific receptors or alter cellular signaling pathways. Its effects are purely physical and mechanical. The duration of effect for ophthalmic povidone is typically 2 to 4 hours, depending on the tear turnover rate of the individual. In the bloodstream, the volume-expanding effect lasts until the polymer is filtered by the kidneys.
| Parameter | Value |
|---|---|
| Bioavailability | 0% (Oral); <1% (Ophthalmic) |
| Protein Binding | 0% (Does not bind to albumin) |
| Half-life | 5-20 hours (Systemic, MW dependent) |
| Tmax | N/A (Non-absorbed) |
| Metabolism | None |
| Excretion | Renal (100% of systemic dose <40kDa) |
Povidone is categorized as a Plasma Volume Expander and a Non-Standardized Chemical Allergen. It is related to other synthetic polymers like Polyethylene Glycol (PEG) and Polyvinyl Alcohol (PVA), but it has unique complexing abilities that make it superior for carrying iodine and stabilizing certain drugs.
Medications containing this ingredient
Common questions about Povidone
Povidone, or polyvinylpyrrolidone, is primarily used as a lubricant in eye drops to treat dry and irritated eyes. It is also a very common 'inactive' ingredient in many tablets and capsules, where it acts as a binder to hold the medication together. Additionally, it is used as a carrier for iodine in antiseptic solutions like Betadine. In emergency medical history, it was used as a plasma volume expander to treat severe blood loss. Today, you will most likely encounter it in over-the-counter artificial tears or as a component of your daily prescription medications.
The most common side effects associated with povidone, particularly in eye drop form, include temporary blurred vision right after application and a mild stinging or burning sensation. Some users may notice a slight redness in the eyes or a watery feeling as the eye adjusts to the lubricant. If used in the form of povidone-iodine on the skin, it can cause mild irritation or a temporary brown stain. Most of these effects are short-lived and do not require medical intervention. However, if irritation persists for more than a few days, you should consult a healthcare provider.
There are no known direct interactions between alcohol and povidone, as povidone is not absorbed into the bloodstream when taken orally or applied to the eyes. However, it is important to remember that alcohol is a diuretic and can lead to systemic dehydration. Dehydration is a leading cause of dry eye symptoms, which is the very condition povidone eye drops are meant to treat. Therefore, while drinking alcohol won't cause a dangerous reaction with the drug, it may make your dry eye symptoms worse. Always maintain adequate hydration for the best results with povidone therapy.
Povidone is generally considered safe during pregnancy when used as an eye drop or consumed as a binder in standard medication tablets. Because it is not absorbed into the mother's system, there is no significant risk to the developing baby. However, you should be cautious with povidone-iodine (antiseptic) products during pregnancy. The iodine in those products can be absorbed through the skin and may affect the baby's thyroid gland development. If you are pregnant, always check with your doctor before using any iodine-containing povidone products for more than a few days.
When used for dry eyes, povidone works almost instantly to provide relief by coating the surface of the eye with a protective, lubricating film. You should feel a reduction in grittiness and irritation within seconds of applying the drops. However, the effect is temporary, usually lasting between two and four hours, depending on the severity of your dryness and environmental factors like wind or air conditioning. For its use as a tablet binder, povidone works by helping the tablet dissolve in your stomach, which typically happens within 15 to 30 minutes of ingestion.
Yes, you can stop using povidone at any time without experiencing withdrawal symptoms or physical dependence. Since it is a lubricant and not a systemic medication that alters your body's chemistry, there is no need to taper the dose. However, if you are using it to manage a chronic condition like dry eye syndrome, you will likely notice that your symptoms return once you stop the treatment. If your eyes become significantly more painful or red after stopping, you should see an eye doctor to rule out other underlying conditions.
If you miss a dose of povidone eye drops, simply apply them as soon as you remember. Povidone is often used on an 'as-needed' basis, so missing a dose is generally not a cause for concern. If it is almost time for your next scheduled application, just skip the missed one and continue with your regular routine. Do not put extra drops in your eye to make up for the missed dose, as this will not provide extra relief and may cause temporary blurring of your vision. Consistency is helpful for chronic dry eye, but occasional missed doses are not harmful.
No, povidone does not cause weight gain. It is a large polymer molecule that is not absorbed by the gastrointestinal tract when taken orally and does not enter the metabolic pathways that regulate weight or appetite. Even if povidone were administered intravenously, it has no caloric value and does not affect fat storage or fluid retention in a way that would lead to weight gain. If you are experiencing unexplained weight gain while taking a medication that contains povidone, the cause is likely the active drug itself or another unrelated health factor.
Povidone in eye drops can generally be used with other medications, but you should wait at least 5 to 10 minutes between applying povidone and any other eye drops. This prevents the second drop from washing out the first one and ensures both are properly absorbed. When povidone is an inactive ingredient in your pills, it does not typically interact with other drugs. However, if you are using povidone-iodine on your skin, you should avoid using it at the same time as silver-based creams or hydrogen peroxide, as they can react and irritate the skin. Always inform your doctor of all products you use.
Povidone is widely available as a generic product and is found in many store-brand 'Artificial Tears' and 'Lubricant Eye Drops.' Because it is a long-standing, well-understood polymer, many manufacturers produce it under various brand names and generic labels. When looking for a generic version, check the 'Active Ingredients' section of the label for 'Povidone' or 'Polyvinylpyrrolidone.' Generic versions are typically just as effective as brand-name versions for relieving dry eye symptoms and are often more cost-effective for long-term use.